Headquartered in San Diego, CA, iXCells Biotechnologies is a leading cell biology and cell technology company specializing in preclinical drug discovery solutions with focus on disease relevant cellular models enabling technologies and services to the academic, biotech and pharma communities. iXCells provides high quality primary cells normal and diseased iPS cell lines, iPSC-derived cell products, custom iPSC services, functional bioassay development and execution, among other products and services.
Axol Bioscience is a leading provider of human induced pluripotent stem cell (iPSC) technologies, specializing in the manufacture of high-performance iPSC-derived cells and the delivery of industry-leading laboratory services. With over a decade of expertise, Axol partners with global pharmaceutical companies, contract research organizations (CROs), biotechnology firms, start-ups, and academic institutions to advance the use of iPSC-based models in drug discovery and disease research.
We operate across five key areas, neuroscience (including ALS, Alzheimer’s, Huntington’s, Parkinson’s, neuroinflammation), pain & sensation, ophthalmology (Dry-AMD, ophthal-inflammation), dermatology, and cardiovascular.
Axol offers scalable solutions including iPSC banking, reprogramming, gene editing, cell manufacturing, and quality control. The company is committed to closing the translational gap, developing physiologically relevant in vitro systems that improve consistency and relevance in human disease modeling and compound testing.
Axol is recognized for its scientific excellence, transparent collaboration, and rigorous quality standards, with manufacturing operations certified to ISO 9001:2015.
Global Leadership in Primary Cells: Excellence in cell isolation, 3D bioprinting, tissue engineering, 3D cell models, stem cells, optimized culture media and more. CAI's products and custom services support basic life science research and biopharmaceutical drug discovery. Our Center for Primary Cell Innovation pushes the edges of technology, with regular advancements developed in collaboration with academic & industry experts.